



Cytogenetic/Molecular Technologist.—The Kleberg cy-
togenetics and molecular cytogetics laboratory at Baylor
College of Medicine has an immediate opening for an
outstanding individual with proven ability in cytogenetics,
FISH, and molecular genetics. The laboratory processes
all types of cytogenetic samples and has a growing di-
agnostic molecular biology and FISH component. Re-
sponsibilities of the position will include establishing and
monitoring quality-control/quality-assurance activities,
implementing new technologies, and troubleshooting
problems encountered in the day-to-day activities of the
laboratory. The preferred candidate should have at least
2 years of experience in a full-service cytogenetics/molec-
ular genetics laboratory, experience in microscopy, and a
B.S. degree or higher in a related field. Salary will be
commensurate with experience. Please send your curric-
ulum vitae to Rizwan C. Naeem, M.D., F.A.C.M.G., As-
sociate Professor, Department of Molecular and Human
Genetics, Director, Kleberg Cytogenetics and Molecular
Cytogenetics Laboratory, Baylor College of Medicine,
One Baylor Plaza, Room 410A, Houston, TX 77030;
telephone: (713) 798-4991; fax: (713) 798-4998; e-mail:
rizwann@bcm.tmc.edu. The laboratory’s administrative
assistant, Narcy Stokes, can be contacted by telephone,
at (713) 798-7576, or by e-mail, at mstokes@bcm.tmc
.edu. To find out more about the Kleberg Cytogenetics
Laboratory, visit our Web site (http://www.imgen.bcm
.tmc.edu/medgen/klebergcytogenetics.htm).
Director of Biostatistics, Tenured Associate or Full Pro-
fessor.—Candidates are invited to apply for a leadership
role as director of the Division of Biostatistics in the
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Department of Epidemiology and Biostatistics and as
associate director for biostatistics and informatics of the
Cancer Center at Case Western Reserve University and
University Hospitals of Cleveland. We seek candidates
with nationally recognized scholarly and scientific ac-
complishments in biostatistics and an enthusiasm for
undertaking translational research. The successful can-
didate will direct the biostatistics graduate program,
which awards both M.S. and Ph.D. degrees, leading
seven faculty engaged in a broad range of research, in-
cluding microarray analysis, statistical genetics, bioin-
formatics, and longitudinal data analysis. In addition,
he or she will collaborate in the design and analysis of
clinical trials and epidemiologic studies. Applicants
should hold an earned doctorate in biostatistics or a
related field. Please submit a curriculum vitae, a state-
ment of research interests, and the names of three ref-
erences to John S. Witte, Department of Epidemiology
and Biostatistics, Case Western Reserve University,
10900 Euclid Avenue, Cleveland, OH 44106-4945; e-
mail: jsw2@po.cwru.edu
Director, Molecular Diagnostics Laboratory.—The De-
partment of Pathology at University of Texas (UT)
Southwestern Medical Center at Dallas is seeking an
M.D. or M.D./Ph.D. who is board-certified in clinical
molecular genetics (American Board of Molecular Ge-
netics) or in molecular genetic pathology (American
Board of Pathology) or is eligible for such certification,
to be director of the Molecular Diagnostics Laboratory
(rank dependent on qualifications). We wish to attract
individuals with laboratory experience whose primary
interest is in the clinical application of molecular and
medical genetic testing. The department has a nationally
recognized basic science and clinical faculty in molecular
genetics and is committed to the continued expansion
and development of a state-of-the-art molecular diag-
nostics laboratory. The successful candidate will be ex-
pected to direct all aspects of an established, high-vol-
ume molecular laboratory consisting of infectious
disease, hematopathology/oncology, and molecular ge-
netics divisions. Strong leadership and vision for the fu-
ture growth and development of molecular and medical
genetic testing is required to support the clinical services,
research, and outreach programs of UT Southwestern
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Medical Center. The clinical programs supported include
infectious disease, transplantation, obstetrics/gynecol-
ogy, hematology/oncology, neurology, gastroenterology,
and cardiology. The Director will also be responsible for
supporting departmental educational programs and the
molecular pathology fellowship program. An individual
research program and collaborative interaction with
other departments are strongly encouraged. Candidate
must be eligible for a Texas medical license. Interested
candidates should send a curriculum vitae, a statement
of interests, and a list of three references to Robert W.
McKenna, M.D., Executive Vice Chair, Department of
Pathology, 5323 Harry Hines Boulevard, Dallas, TX,
75390-9072. All communications will remain confiden-
tial. UT Southwestern Medical Center is an equal op-
portunity/affirmative action employer.
Director of Cytogenetics and Molecular Genetics.—The
Department of Pathology and Laboratory Medicine at
the Children’s Memorial Hospital in Chicago, IL, invites
applications for the position of director of cytogenetics
and molecular genetics. This full-time, continuing po-
sition carries a primary faculty appointment at North-
western University at a rank commensurate with expe-
rience and academic activity. The director will be
responsible for the administrative, clinical, and scientific
direction of a laboratory that, annually, will analyze 500
lymphocyte/fibroblast cultures for constitutional abnor-
malities, 125 leukemia cultures, and 25 solid tumors. In
addition, fluorescence in situ hybridization, comparative
genomic hybridization, and molecular analysis are es-
tablished procedures in the laboratory. The candidate
should be certified in cytogenetics by the American
Board of Medical Genetics. Preference will be given to
candidates with certification in molecular genetics.
Teaching of pathology and laboratory-medicine resi-
dents and medical students will be expected. The Chil-
dren’s Memorial Medical Center is an independent, mul-
tispecialty, free-standing hospital that provides
tertiary-care pediatric services with active programs in
all pediatric specialties, including genetics, hematology
and oncology, and stem-cell and solid-organ transplan-
tation. In addition, the Children’s Memorial Institute for
Education and Research offers a rapidly expanding re-
search facility and a vibrant research environment. Ap-
plications will be accepted until the position is filled, and
the start date is negotiable. A curriculum vitae, a state-
ment describing previous experience, and three refer-
ences should be submitted to Elizabeth J. Perlman,M.D.,
c/o Pauline Chou, M.D., Children’s Memorial Hospital,
2300 Children’s Plaza, Chicago, IL 60614. Inquiriesmay
be directed by telephone to Dr. Perlman at (410) 614-
0320 or to Dr. Chou at (773) 880-4438. Northwestern
University and Children’s Memorial Hospital are affir-
mative action/equal opportunity employers. Hiring is
contingent upon eligibility to work in the United States.
Women and minorities are encouraged to apply.
Tenure-Track Position, National Institute on Deafness
and Other Communication Disorders.—The Section on
Systems Biology of Communication Disorders at the
Laboratory of Molecular Genetics of the National In-
stitute on Deafness and Other Communication Disor-
ders (NIDCD) in the National Institutes of Health is
seeking an experienced geneticist with an active research
program devoted to the mapping and identification of
genes involved in human speech and language impair-
ment and their underlying functions in the nervous sys-
tem. The NIDCD offers an excellent working environ-
ment, including a well-equipped laboratory and a
community of scholars (http://www.nidcd.nih.gov/in-
tram/basic.htm). Candidates for this position must have
a Ph.D. and/or an M.D., comprehensive advanced train-
ing, an outstanding publication record of peer-reviewed
papers, and the demonstrable ability to conceive and
conduct an independent research program. Salary, re-
sources, and personnel support will be commensurate
with education and experience. U.S. citizenship or per-
manent residency is required. The successful candidate
is expected to maintain a program of independent re-
search that is pertinent to the goals of the section. By
April 30, 2002, please send an application—including a
detailed curriculum vitae, recent reprints, a statement of
research interests and long-term research goals, and
three letters of recommendation—to Ms. Gayle Mun-
dell, Personnel Management Specialist, National Insti-
tute on Deafness and Other Communication Disorders,
31 Center Drive, MSC 2320, Bethesda, MD 20892-
2320; telephone: (301) 402-0508; TDD: (301) 402-
1562; e-mail: mundellg@nidcd.nih.gov. TheNational In-
stitutes of Health is an equal opportunity employer.
Genetic Counseling Associate.—The Center for Human
Genetics at Boston University School of Medicine has
an immediate opening for another board-certified or
board-eligible genetic counseling associate or nurse ge-
neticist. The position involves (1) coordination of a busy
DNA diagnostic program and (2) genetic counseling in
the genetics clinic and the high-risk perinatal clinic. In-
volvement in research projects is encouraged. Some ex-
perience is preferred but is not required. Contact Aubrey
Milunsky, M.D., D.Sc., Center for Human Genetics,
Boston University School of Medicine, 715 Albany
Street, Boston, MA 02118; telephone: (617) 638-7083;
fax: (617) 638-7092; email: amilunsk@bu.edu
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Computational Biologist.—Biogen, one of the world’s
leading biotechnology companies with one of the most
impressive pipelines in the industry, is seeking a com-
putational biologist to assume responsibility for a drug
target database. In this position, located in Cambridge,
MA, the successful applicant will conduct self-directed
research and collaborate with colleagues in bioinfor-
matics, molecular biology, genetics, and structural bi-
ology to develop and maintain a drug target database.
The successful applicant’s primary responsibility will be
to design and implement methods of identifying, clas-
sifying, and annotating secreted and cell-surface proteins
using data from public and private genome databases.
The ideal candidate will possess a Ph.D. and 2 years
of experience with DNA- and protein-sequence–analysis
tools. Extensive experience with DNA and protein-se-
quence–analysis tools, intimate knowledge of public ge-
nome databases, and broad familiarity with methods of
protein-motif identification and classification are de-
sired. The ability to program in PERL or SQL is a plus.
Visit our Web site (http://www.biogen.com/site/content/
index.asp) for details on all of our exciting career op-
portunities in Cambridge, MA; Research Triangle Park,
NC; and Europe. We have one of the strongest financial
profiles in the industry, and our compensation and ben-
efits package, including equity participation, is un-
matched. For consideration, please forward your re-
sume, indicating job code CM089-ASHG, by e-mail, to
resumes@biogen.com. Only the job code should appear
in the subject line. Hard copies should be sent to Biogen,
Attn. Human Resources, 14 Cambridge Center, Cam-
bridge, MA 02142. Biogen is an equal opportunity
employer.
Statistical Geneticist.—Roche Molecular Systems, a
leader in the field of DNA-based diagnostic tests, located
in Alameda and Berkeley, CA, is looking for a statistical
geneticist/biostatistican to join its multidisciplinary
Complex Disease Group. The successful candidate will
work on a variety of projects, including evaluation of
whether candidate genes or haplotypes influence disease
occurrence and analysis of mRNA profiling data. Re-
sponsibilities will also include review of potential
publications for statistical accuracy and writing reports
for in-house team members as well as outside collabo-
rators. Qualifications for the position include familiarity
with a wide range of statistical methods, such as
ANOVA, logistic-regression analysis, survival analysis,
linkage analysis, and multivariate analysis. Knowledge
of genetics and experience in analysis genetic data are
preferred. Proficiency in Splus or SAS is necessary. A
Ph.D. or master’s degree in statistics, biostatistics, sta-
tistical genetics, or genetic epidemiology is required.
Good communication skills are required. Please submit
your resume via e-mail to bonnie.fijal@roche.com
Associate Director of Cytogenetics.—The City of Hope
National Medical Center (COH) invites applications for
the position of associate director of cytogenetics. The
candidate must have a doctoral degree (M.D. or Ph.D.)
and should be certified in cytogenetics by the American
Board of Medical Genetics. Experience in cancer cyto-
genetics and molecular cytogenetics techniques is desir-
able. COH is a National Cancer Institute–affiliated clin-
ical cancer center and research institution dedicated to
the diagnosis and treatment of hematologicmalignancies
and solid tumors. Responsibilities include administra-
tion, teaching, and supervision of a cancer cytogenetics
diagnostic laboratory (∼2,500 samples/year). Develop-
ment of an independent genetics-based research program
is encouraged but not mandatory. A curriculum vitae, a
statement describing previous experience, and three ref-
erences should be submitted toMarilyn L. Slovak, Ph.D.,
City of Hope National Medical Center, Department of
Cytogenetics, Northwest Building, Room 2255, 1500
East Duarte Road, Duarte, CA 91010-0269. Applica-
tions and inquiries may be submitted by e-mail to
mkyle@coh.org. COH is an affirmative action/equal op-
portunity employer. Hiring is contingent on eligibility to
work in the United States. For additional information
about our medical center, please visit our Web site (http:
//www.cityofhope.org/).
Director of Molecular Genetics.—The Genetics Center
in Orange, CA (Disneyland area), has an immediate
opening for a director of its molecular genetics labora-
tory. The molecular genetics laboratory currently offers
a wide range of diagnostic assays. Candidates should
have a doctorate degree (Ph.D., M.D., or M.D./Ph.D.),
should be board certified or eligible for a California Ge-
netics Laboratory Directorship, and should have signif-
icant experience in DNA-based testing. Responsibilities
will include interpretation and signing out of test results,
supervision of the molecular laboratory, participation in
laboratory activities, and development of new tests and/
or technology. The Genetics Center is a comprehensive
center with molecular genetics and cytogenetics labo-
ratories, plus genetic counseling services and extensive
genetics clinics. The Genetics Center has been in oper-
ation for 16 years and has been in our new building,
with facilities custom built for us, for over a year now.
We are a CME provider with an active continuing-ed-
ucation program, and opportunities are available to par-
ticipate in educational activities. For more information,
visit our Web site (http://www.geneticscenter.com/). We
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offer full benefits, a very pleasant environment, and com-
petitive salaries. A curriculum vitae, along with a cover
letter detailing experience and future interests, should
be sent to The Genetics Center, Attn.: Robert Meyer,
Vice President, 211 South Main Street, Suite E, Orange,
CA 92868; fax: (714) 288-8525; telephone: (714) 288-
8520; e-mail: nzadeh@aol.com
FELLOWSHIP
Training Fellowship in Clinical Cytogenetics—Applica-
tions are invited for a 2–3-year training fellowship in clin-
ical cytogenetics at the Kleberg cytogenetics laboratory in
the Department of Molecular and Human Genetics at
Baylor College of Medicine. The central aim of the fel-
lowship is eligibility for certification in clinical cytoge-
netics by the American Board ofMedical Genetics. Ample
opportunities for research are also available. Candidates
with an M.D. or Ph.D. degree who have a strong back-
ground in cancer and molecular biology are encouraged
to apply. Please send a copy of your resume´ and personal
statement to Rizwan C. Naeem, M.D., F.A.C.M.G., As-
sociate Professor, Department of Molecular and Human
Genetics, Director, Kleberg Cytogenetics and Molecular
Cytogenetics Laboratory, Baylor College of Medicine,
One Baylor Plaza, Room 410A, Houston, TX 77030;
telephone: (713) 798-4991; fax: (713) 798-4998; e-mail:
rizwann@bcm.tmc.edu. The laboratory’s administrative
assistant, Narcy Stokes, can be contacted by telephone,
at (713) 798-7576, or by e-mail, at mstokes@bcm.tmc
.edu. To find out more about the Kleberg Cytogenetics
Laboratory, visit our Web site (http://www.imgen.bcm
.tmc.edu/medgen/klebergcytogenetics.htm).
AWARDS
Allan Award.—The Allan Award is the highest honor
bestowed by the American Society of Human Genetics
(ASHG) and was established in 1961 in memory of Wil-
liam Allan (1881–1943), one of the first American phy-
sicians to conduct extensive research in human genet-
ics. The Allan Award is presented annually to recognize
sustained and outstanding scientific contributions to hu-
man genetics. The Allan Award comprises a medal and
$10,000, which is granted as a personal prize. The
awardee is invited to present a 30–45-min plenary ad-
dress to the ASHG at the annual meeting and is asked
to submit a manuscript to The American Journal of Hu-
man Genetics. The award is not contingent on the ad-
dress or the submission of a manuscript. A listing of
previous Allan award winners can be found at the ASHG
Web site (http://www.faseb.org/genetics/ashg/meet-2001
/P-A/awards.htm). Nomination for the Allan Award
should be based on a body of substantial and sustained
scientific contributions, made over a lifetime, to human
and medical genetics. A single scientific contribution is
not considered sufficient. Both American and overseas
scientists may be proposed. Awardees will usually be
ASHG members, but membership is not required. Usu-
ally, a single recipient should be nominated. If two sci-
entists have collaborated or have contributed indepen-
dently to the topic for which the award is given, two
individuals may be nominated. Each will receive the full
amount of the award. All members of the Society are
urged to submit a single nomination. Please submit a
letter documenting the nominee’s significant and sus-
tained contributions to the field of human genetics.
Nomination letters must be received by April 15, 2002,
to be considered. Please send them to Joann A. Bough-
man, Ph.D., Executive Vice President, American Society
of Human Genetics, 9650 Rockville Pike, Bethesda,MD
20814; telephone: (301) 571-1825; fax: (301) 530-7079;
e-mail: jboughman@ashg.org
Stern Award.—The Stern Award was instituted by the
American Society of Human Genetics (ASHG) in 2001
and honors the memory of Curt Stern (1902–81) as an
outstanding pioneer in human genetics and the ASHG
President in 1956. This award will be granted annually
to a scientist for major scientific achievement in human
genetics that occurred in the past 10 years. The award
comprises a personal prize of $2,500 and an engraved
crystal piece. Nomination for the Stern Award should be
based on a major scientific discovery or a series of con-
tributions on a similar or related topic during the past 10
years (whereas the Allan Award honors lifetime achieve-
ments). Both American and overseas scientists may be
proposed. Awardees will usually be ASHG members, but
membership is not required. Usually, a single recipient
should be nominated. If two scientists have collaborated
or have contributed independently to the topic for which
the award is given, two individuals may be nominated.
Each will receive the full amount of the award. All mem-
bers of the Society are urged to submit a single nomi-
nation. Please submit a letter documenting the nominee’s
significant contribution to the last decade of discovery in
human genetics. The nomination must be received by
April 15, 2002, to be considered. Please send them to
Joann A. Boughman, Ph.D., Executive Vice President,
American Society of Human Genetics, 9650 Rockville
Pike, Bethesda, MD 20814; telephone: (301) 571-1825;
fax: (301) 530-7079; e-mail:jboughman@ashg.org
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ASHG Award for Excellence in Human Genetics Edu-
cation.—The American Society of Human Genetics
(ASHG) has established an award to recognize outstand-
ing contributions to human genetics education. Nomi-
nations for this award are now being solicited frommem-
bers of the Society. Nominees must have made a
contribution that is recognized nationally or internation-
ally as being of exceptional quality and great importance
to human genetics education. Examples would include
producing a set ofwritings that have had amajor influence
on human genetics education, developing a course that is
widely emulated, writing a book that has been adopted
bymany universities, producing a popular television series
on medical genetics, or directing a fellowship program
that has consistently produced unusually successful grad-
uates. The range of possible contributions to human ge-
netics education is great, but the quality and impact of
the contributionmust be exceptional. AnyASHGmember
may propose a candidate for nomination by submitting
appropriate documentation to the Information and Ed-
ucation Committee. This documentation should consist
of a detailed description of the individual’s qualifications
and educational contribution(s), as well as letters of sup-
port from two other ASHG members. The Committee
will choose at least three individuals as nominees each
year and will prepare a standard dossier on each. These
dossiers will be provided to the ASHGAwardsCommittee
for consideration prior to the annual meeting. The recip-
ient of the award will be selected by the ASHG Awards
Committee from the nominations submitted to it by the
Information and Education Committee. The Awards
Committee may choose not to present the award in a
given year if, in its opinion, none of the nominees is a
suitable recipient. Previous award recipients areMargaret
Thompson, Barton Childs, Victor McKusick, C. C. Li,
Arno Motulsky, F. Clarke Fraser, and Charles Scriver.
Nominations and supporting documents must be received
by April 15, 2002, to be considered for the award. Please
submit complete documentation and letters of recom-
mendation in support of the nomination to ASHG In-
formation and Education Committee, c/o Jane Doran Sal-
omon, M.S., The American Society of Human Genet-
ics, 9650 Rockville Pike, Bethesda, MD 20814; e-mail:
jsalomon@ashg.org
MEETINGS
Third International Meeting on the Genetic Epidemi-
ology of Complex Traits.—This meeting will be held
April 4–6, 2002, at Churchill College, Cambridge Uni-
versity, Cambridge, United Kingdom. Its content will
include a 1-day introductory course on the genetic ep-
idemiology of complex diseases, covering design and an-
alytical issues; a 2-day conference program with updates
from international speakers, aimed at a more advanced
audience; a forum where researchers can present their
questions to panels of experts; and poster presentations.
The introductory/refresher course will include an over-
view of methods and designs, association studies, linkage
studies and packages, TDT analysis, current and novel
molecular-biology methods for gene discovery, variance-
components analysis, and animal models. Advanced top-
ics will include extent of linkage disequilibrium, gene-
expression analysis, combined association and linkage
studies, Bayesian QTL analysis, epidemiology, novel
methods, meta-analysis, DNA pooling, clinical exam-
ples, and haplotype analysis. International speakers and
chairs will include Gonc¸alo Abecasis, Cathryn Lewis,
David Balding, Klaus Lindpainter, John Blangero, Alex
MacGregor, Dorret Boomsma, Nick Martin, Lon Car-
don, Paul McKeigue, Robert Elston, Newton Morton,
Jonathan Flint, Mike Neale, Philippe Froguel, Shaun
Purcell, David Goldstein, Nik Schork, Jaako Kaprio,
Pak Sham, Augustine Kong, Harold Snieder, Jerry
Lanchbury, and Tim Spector. For information on reg-
istration and abstracts, visit our Web site (http://
www.twin-research.ac.uk/) or send an e-mail message to
Cambridge2002@twin-research.ac.uk
International DNA Sampling Conference.—The 3d In-
ternational DNA Sampling Conference will be held in
Montreal, Canada, September 5–8, 2002. The confer-
ence will be hosted by the Center for Research in Law
of the University of Montreal, the Health Law Institute
of the University of Alberta, and the Network for Ap-
plied Genetic Research of Quebec. This conference will
bring together leaders, researchers and policy-makers to
examine the following themes: “PopulationGenetics and
Community Genetics,” “Research: DNA Sampling and
Banking,” “Public and Private Databases,” “Discrimi-
nation,” “Benefit-Sharing,” and “Patents.” For addi-
tional information, please visit the conference Web site
(http://www.humgen.umontreal.ca/conference/en/) or
reach us by telephone at (514) 343-2142.
Genetic Testing and Public Policy: Preparing Health
Professionals.—This conference will be held May 13,
2002, in Baltimore, MD. Educating health care profes-
sionals about genetics is a high priority of the Secretary’s
Advisory Committee on Genetic Testing (SACGT), be-
cause of its critical importance to ensuring the appro-
priate use of genetic tests. As the use of genetic testing
expands into many areas of health care, the capacity of
health care professionals to provide accurate and up-to-
date information to patients and consumers becomes
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essential. Through a combination of plenary presenta-
tions and panel discussions, this conference will explore
the integration of genetics into primary care, will high-
light the use of family-history taking as a primary pre-
dictive test, and will discuss the various roles of health
care providers in the provision of genetics services. Af-
ternoon focus groups will concentrate on several differ-
ent areas of genetics education, training, and integration.
Recommendations from the conference will be consid-
ered by the SACGT for proposal to the Secretary of
Health and Human Services. The meeting is open to the
public and free to all participants. A catered luncheon
is offered at the cost of $30. All lunch reservations must
be made in advance. For meeting information and reg-
istration, see the SACGT Web site (http://www4.od.nih
.gov/oba/sacgt.htm).
SUBJECTS NEEDED
Identical Twins with Tuberous Sclerosis Needed for Re-
search Study.—Dr. David Kwiatkowski and colleagues
are seeking identical twins with tuberous sclerosis (TSC)
for a research study investigating the genetic basis of
variability in clinical manifestations of TSC. Review of
medical records, contact with treating physicians, and a
blood sample for analysis for mutations in the TSC genes
will be required. For more information or if you are
willing to participate, please contact Dr. Kwiatkowski
at Genetics Laboratory, Hematology Division, Brigham
& Women’s Hospital, Harvard Medical School, 221
Longwood Avenue, Boston, MA 02115; telephone:
(617) 278-0384; fax: (617) 734-2248; e-mail: dk@rics
.bwh.harvard.edu
Patients or Families with Jeune Syndrome (Asphyxiating
Thoracic Dystrophy).—Our research group is seeking to
map and clone the gene that underlies Jeune syndrome.
We have already recruited a number of affected consan-
guineous families and are now performing a homozy-
gosity mapping study, with the approval of the Institute
of Child Health’s research ethics committee. If you know
of any patients or families with Jeune syndrome, espe-
cially consanguineous families, who might be willing to
participate in this project, we would greatly appreciate
hearing from you. Please contact Dr. Frances Goodman
(fgoodman@hgmp.mrc.ac.uk) or Prof. Peter Scambler
(pscamble@hgmp.mrc.ac.uk) at the Molecular Medicine
Unit, Institute of Child Health, 30 Guilford Street, Lon-
don WC1N 1EH, United Kingdom; telephone:44 (20)
7242-9789 x2432; fax: 44 (20) 7404-6191.
REQUEST FOR RESEARCH PROPOSALS
Angelman Syndrome.—The Angelman Syndrome Foun-
dation USA announces the availability of $75,000 to be
awarded in support of research on Angelman syndrome
(AS). All areas of biomedical and behavioral research
involving AS will be considered. The Angelman Syn-
drome Foundation will be flexible regarding the number
of awards made and the amount of funding for each.
Deadline for receipt of applications will be March 15,
2002. Applications should be assembled following these
general guidelines: a one-page summary abstract of pro-
posed research; the main body of the proposal, which
should not exceed six pages in length and should include
identification of the primary investigator, a summary of
his or her background, hypothesis, methods, the signif-
icance of the proposed research, and a time frame for
its completion; a one-page budget summary and justi-
fication (no indirect costs will be allowed); a curriculum
vitae of the principal investigator(s); and letters of sup-
port/collaboration, where necessary. Proposals dealing
with human or animal subjects must conform to the
usual review by an institutional review board; a copy of
approval must be provided before funding is released.
A cover letter and 10 copies of the above should be
submitted to the Scientific Advisory Committee, Angel-
man Syndrome Foundation USA, c/o Prof. Daniel F. Har-
vey, Ph.D., 414 Plaza Drive, Suite 209, Westmont, IL
60559. Proposals will be reviewed by the Scientific Ad-
visory Committee of the Angelman Syndrome Founda-
tion. Questions about this announcement should be di-
rected to Angelman Syndrome Foundation, 414 Plaza
Drive, Suite 209, Westmont, IL 60559; telphone: (800)
432-6435; fax: (630) 655-0391; e-mail: info@angelman
.org. See our Web site (http://www.angelman.org/call_
for_proposals.htm).
RESOURCE FOR GENETICS RESEARCH
Gene Discovery Project.—The Epilepsy Foundation in-
vites applications from scientists who wish to gain access
to the pedigree information entered into the Foundation’s
Gene Discovery Project relational database. The Epilepsy
Foundation, via its Web site, is collecting data on a vol-
untary and confidential basis from people who have a
family history of epilepsy. Approved researchers are
granted access to query the database and to select pedi-
grees that match their genetic studies. The Epilepsy Foun-
dation will serve to introduce researchers to families they
may wish to invite to participate in a specific study. More
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information about the Gene Discovery Project can be
found by visiting the project Web site (http://www
.epilepsyfoundation.org/gene/). Inquiries are invited from
researchers who meet all the eligibility criteria outlined in
the application. All research must be conducted within
the United States. Applications are accepted on a rolling
basis throughout the year. Applications can be found
on the Web (http://www.epilepsyfoundation.org/GDP
application/) or by contacting the Epilepsy Foundation,
Gene Discovery Project, 4351 Garden City Drive, Lan-
dover, MD 20785-2267; telephone: (301) 459-3700;
fax: (301) 577-2684; e-mail: grants@efa.org
